Autoimmunity involving the human sodium/iodide symporter: Fact or fiction?

Summary:

Presence, functional activity and clinical relevance of autoantibodies directed against the human sodium iodide symporter (NIS) in thyroid autoimmune diseases have become the subject of much controversy in recent years. Earlier reports have claimed that NIS may represent a major thyroid autoantigen that elicits formation of functionally relevant autoantibodies in a significant proportion of patients with Graves' disease (GD) and Hashimoto's thyroiditis (HT). Moreover, a recent study has extended this notion by reporting detection of NIS-autoantibodies in 22% and 24% of a small number of patients with GD and HT, respectively, but not in patients with other autoimmune diseases. However, in striking contrast to these reports, two independent groups of investigators have now presented convincing evidence that NIS-directed autoantibodies occur with low frequency among a large sample of patients with autoimmune thyroid diseases. Moreover, no evidence of specific iodide uptake inhibiting activity was obtained once sera had been subjected to dialysis and/or IgG extraction. Thus, although the controversy has not been definitively resolved, hNIS does not appear to be a major functionally relevant antigen in autoimmune thyroid diseases. Moreover, when detected in addition to TPO and TSH receptor autoantibodies, NIS-directed autoantibodies do not appear to contribute any diagnostic power for GD and HT.

Key words:

Sodium/iodide symporter - NIS - autoimmunity - antibodies - autoantigen

References

• 1 Ajjan R A, Findlay C, Metcalfe R A, Watson P F, Crisp M, Ludgate M, Weetman A P. The modulation of the human sodium iodide symporter activity by Graves' disease sera.  J Clin Endocrinol Metab. 83 1217-1221 1998; 
• 2 Ajjan R A, Kemp E H, Waterman E, Watson P, Endo T, Onaya T, Weetman A. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.  J Clin Endocrinol Metab. 85 2020-2027 2000; 
• 3 Ajjan R A, Watson P F, McIntosh R S, Weetman A P. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis.  Clin Exp Immunol. 105 523-528 1996; 
• 4 Bidart J-M, Mian C, Lazar V, Russo D, Filetti S, Caillou B, Schlumberger M. Expression of pendrin and the pendred syndrome (PDS) gene in human thyroid tissues.  J Clin Endocrinol Metab. 85 2028-2033 2000; 
• 5 Caillou B, Troalen F, Baudin E, Talbot M, Filetti S, Schlumberger M, Bidart J M. Na⁺/I^- symporter distribution in human thyroid tissues: An immunohistochemical study.  J Clin Endocrinol Metab. 83 4102-4106 1998; 
• 6 Carrasco N. Iodide transport in the thyroid gland.  Biochem Biophys Acta. 1154 65-82 1993; 
• 7 Castro M R, Bergert E R, Beito T G, McIver B D, Goellner J R, Morris J C. Development of monoclonal antibodies against the human sodium iodide symporter: Immunohistochemical characterization of this protein in thyroid cells.  J Clin Endocrinol Metab. 84 2957-2962 1999; 
• 8 Chin H S, Chin D K, Morgenthaler N G, Vassart G, Costagliola S. Rarity of anti- Na⁺/I^- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).  J Clin Endocrinol Metab. 2000;  85 3937-3940
• 9 Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter.  Nature. 379 458-460 1996; 
• 10 De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.  Physiol Rev. 80 1083-1105 2000; 
• 11 Endo T, Kaneshige M, Nakazato M, Kogai T, Saito T, Onaya T. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.  Biochem Biophys Res Commun. 228 199-202 1996a; 
• 12 Endo T, Kogai T, Nakazato M, Saito T, Kaneshige M, Onaya T. Autoantibody against Na⁺/I^- symporter in the sera of patients with autoimmune thyroid disease.  Biochem Biophys Res Commun. 224 92-95 1996b; 
• 13 Furlanetto T W, Nguyen L Q, Jameson J L. Estradiol increases proliferation and downregulates the sodium/iodide symporter gene in FRTL-5 cells.  Endocrinology. 140 5705-5711 1999; 
• 14 Joba W, Spitzweg C, Schriever K, Heufelder A E. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.  Thyroid. 9 455-466 1999; 
• 15 Kawaguchi A, Ikeda M, Endo T, Kagai T, Miyazaki A, Onaya T. Transforming growth factor-b1 suppresses thyrotropin-induced Na⁺/I^- symportor messenger ribonucleic acid levels in FRTL-5 cells.  Endocrinology. 139 703-712 1997; 
• 16 Levy O, De la Vieja A, Ginter C S, Riedel C, Dai G, Carrasco N. N-linked glycosylation of the thyroid Na⁺/I^- symportor (NIS): implications for its secondary structure model.  J Biol Chem. 273 22657-22663 1998; 
• 17 Morris J C, Bergert E R, Bryant W P. Binding of IgG from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: Evidence for the iodide transporter as an autoantigen.  Thyroid. 7 527-534 1997; 
• 18 Paire A, Bernier-Valentin F, Selmi-Ruby S, Rousset B. Characterization of the rat thyroid iodide transporter using anti-peptide antibodies.  J Biol Chem. 272 18245-18249 1997; 
• 19 Pekary A E, Hershman J M. Tumor necrosis factor, ceramide, transforming growth factor-b1, and aging reduce Na⁺/I^- symporter messenger ribonucleic acid levels in FRTL-5 cells.  Endocrinology. 139 703-712 1998; 
• 20 Raspe E, Costagliola S, Ruf J, Mariotti S, Dumont J E, Ludgate M. Identification of the thyroid Na⁺/I^- cotransporter as a potential autoantigen in thyroid autoimmune disease.  Eur J Endocrinol. 132 399-405 1995; 
• 21 Royaux I, Suzuki K, Mori A, Katoh R, Everett L A, Kohn L D, Green E D. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells.  Endocrinology. 141 839-845 2000; 
• 22 Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T. Increased expression of the Na⁺/I^- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.  J Clin Endocrinol Metab. 82 3331-3336 1997; 
• 23 Scott D A, Wang R, Kreman T M, Sheffield V C, Karniski L P. The Pendred syndrome gene encodes a chloride-iodide transport protein.  Nat Genet. 21 440-443 1999; 
• 24 Seissler J, Wagner S, Schott M, Feldkamp J, Scherbaum W A, Morgenthaler N G. Low frequency of autoantibodies to the human Na⁺/I^- symporter (NIS) in patients with autoimmune thyroid disease.  J Clin Endocrinol Metab. 2000;  85 4630-4634
• 25 Smanik P A, Liu Q, Furminger T L, Ryu K, Xing S, Mazzaferri E L, Jhiang S M. Cloning of the human sodium iodide symporter.  Biochem Biophys Res Commun. 226 339-345 1996; 
• 26 Smanik P A, Ryu K-Y, Thiel K S, Mazzaferri E L, Jhiang S M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.  Endocrinology. 138 3555-3558 1997; 
• 27 Spitzweg C, Joba W, Morris J C, Heufelder A E. Regulation of sodium iodide symporter gene expression in FRTL-5 cells.  Thyroid. 9 821-830 1999; 
• 28 Suzuki K, Mori A, Saito J, Moriyama E, Ullianich L, Kohn L D. Follicular thyroglobulin suppresses iodide uptake by supressing expression of the sodium/iodide symporter gene.  Endocrinology. 140 5422-5430 1999; 
• 29 Weetman A P, McGregor A M. Autoimmune thyroid disease: further developments in our understanding.  Endocr Rev. 15 788-830 1994; 
• 30 Yamazaki K, Yamada E, Kanaji Y, Shizume K, Wang D S, Maruo N, Obara T, Sato K. Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles.  Endocrinology. 137 4857-4863 1996; 
• 31 Zheng R Q, Abney E R, Chu C Q, Field M, Maini R N, Lamb J R, Feldmann M. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.  Immunology. 75 456-462 1992;